Lv31
208 积分 2022-12-04 加入
Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients
9天前
已完结
1929O Soluble PD-L1 and circulating CD8+PD1+ and NK cells enclose a highly prognostic and predictive immune effector score in immunotherapy treated NSCLC patients
9天前
已关闭
ILC2s drive allergen recall
10天前
已完结
Circulating T-cell Immunosenescence in Patients with Advanced Non–small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy
10天前
已完结
Circulating T-cell Immunosenescence in Patients with Advanced Non–small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy
10天前
已完结
Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer
24天前
已完结
Immunological characteristics of peripheral T cells as prognostic markers for Camrelizumab and Apatinib combination therapy in advanced squamous non-small-cell lung cancer
26天前
已完结
Systemic activation and tissue infiltration of CD8 + CX3CR1 + T cells in non-small cell lung cancer treated with neoadjuvant immune checkpoint blockade
26天前
已完结
Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy
1个月前
已完结
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion
1个月前
已完结
皖公网安备34019202002308
